Peter A. Forsberg
- Co-authors
- Tomer M. MarkDaniel W. SherbenouÁtila Madureira BuenoRasmus Oestergaard NielsenAdam HulmeZachary J. WalkerDaniel RamskovCamma Damsted
- Topics
- Multiple Myeloma Research and Treatments (32 papers)Protein Degradation and Inhibitors (17 papers)Chronic Lymphocytic Leukemia Research (7 papers)
- Cited by
- HematologyOncologyTransplantation
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Peter A. Forsberg
37 papers receiving 354 citations
Peers
Comparison fields: 5 of 60
- Hematology 199
- Oncology 165
- Molecular Biology 137
- Immunology 69
- Radiology, Nuclear Medicine and Imaging 42
Countries citing papers authored by Peter A. Forsberg
This map shows the geographic impact of Peter A. Forsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Forsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Forsberg more than expected).
Fields of papers citing papers by Peter A. Forsberg
This network shows the impact of papers produced by Peter A. Forsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Forsberg. The network helps show where Peter A. Forsberg may publish in the future.
Co-authorship network of co-authors of Peter A. Forsberg
This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Forsberg. A scholar is included among the top collaborators of Peter A. Forsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Forsberg. Peter A. Forsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 0 | |
| 12 | 9 | |
| 13 | 65 | |
| 14 | 39 | |
| 15 | 6 | |
| 16 | 27 | |
| 17 | 4 | |
| 18 | 6 | |
| 19 | Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. | 29 |
| 20 | 19 |
About Peter A. Forsberg
Peter A. Forsberg is a scholar working on Hematology, Genetics and Oncology, having authored 40 papers that have together received 359 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (17 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Hematology (199 citations), Oncology (165 citations) and Transplantation (16 citations). Peter A. Forsberg has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Tomer M. Mark, Daniel W. Sherbenou, Átila Madureira Bueno, Rasmus Oestergaard Nielsen, Adam Hulme, Zachary J. Walker, Daniel Ramskov, Camma Damsted, Amrita Krishnan and Clayton A. Smith. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.